Other News To Note
Monday, April 23, 2012
Athersys Inc., of Cleveland, said preclinical data published in Cell Transplantation suggested MultiStem could provide benefit to patients suffering from lysosomal storage disorders such as MPS-1 disease, also known as Hurler's syndrome.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.